VentriPoint Diagnostics Ltd V.VPT

RE:See Ventripoint last week's news👀 BEST GEN3EHO on Planet 🚀

[jopatclo]

jopatclo wrote: FDA V4.0 and Sales at any time now Insiders know! (Ventripoint selected as a trusted solution for cardiac imaging ; presented at Take Heart conference)
See Ventripoint last week's news The BEST automation and analysis on the PLANET GEN3EHO On website Ascend https://ascendcv.com/ (Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.)
FDA 4.0 News and Sales? Maybe before BSEcho 2024 ?See Logo Ventripoint ! We currently have eight annual partners: Logo Ventripoint + PHILIPS +GE HealthCare + FUJIFILM and other major healthcare companies...https://www.bsecho.org/Public/Public/About-Us/Partners/Industry-partners.aspx?hkey (Imagine ? Mayo Clinic Ranks First In Hospital AI Readiness Index ) (Sales or FDA V4.0) its going up $$
Reminder of July 5, 2023 !
Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany (July 4 = low 0.13 and July 24 = high 0.325 $)
Remember pictures Hall Mayo Clinic

Hugh MacNaughtHugh MacNaught • Following • FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.1mo • 1 month ago

 

Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies.

Activate to view larger image,

Remember The weekend at #BSEcho2023

Ventripoint Diagnostics Ltd.Ventripoint Diagnostics Ltd.1,208 followers1,208 followers11mo • 1 year ago

 

The weekend at hashtag#BSEcho2023 was a huge success and was filled with discussions on the latest research on cardiovascular research and echocardiography. Ventripoint’s booth showed live demonstrations using the VMS+ and we had engaging conversations with many attendees. Thank you to the British Society of Echocardiography for organizing a fantastic event!

Activate to view larger image,

  The BEST automation and analysis on the PLANET GEN3EHO On website Ascend https://ascendcv.com/ Clic On integration see Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care. Key Features Gen3Echo combines the core capabilities of ASCEND CV Structured Reporting, InView DICOM Echo Viewer, flexible analytics, and AI integrations to provide a complete, seamless solution for echo interpretation. Together, ASCEND’s portfolio of trusted products elevates echo reading and reporting workflow to a new level of productivity: